Teneligliptin & Pioglitazone ''"

Teneligliptin & Pioglitazone
TENELIGOLD PIO 20/15  
Teneligliptin is a medication that belongs to the class of drugs known as dipeptidyl peptidase-4 (DPP-4) inhibitors. Teneligliptin works by inhibiting the DPP-4 enzyme, which is responsible for breaking down incretin hormones like GLP-1 (glucagon-like peptide-1). GLP-1 helps to regulate blood sugar levels by increasing insulin secretion and reducing glucagon release. By inhibiting DPP-4, teneligliptin prolongs the action of GLP-1, leading to better blood sugar control after meals.
Pioglitazone medication is classified as a thiazolidinedione (TZD) and is commonly referred to as an insulin sensitizer. Pioglitazone primarily works by targeting insulin resistance, which is a common feature of type 2 diabetes. It activates peroxisome proliferator-activated receptor gamma (PPARγ) in fat, muscle, and liver tissues. Activation of PPARγ leads to improved insulin sensitivity, reduced glucose production by the liver, and enhanced glucose uptake by peripheral tissues.
Steris Healthcare Pvt. Ltd. is a Leading Pharmaceutical Company in India. Established in the year of May 2018. We have 750+ Products & 16+ Super Specialty Segments. Every week we have a new product in our portfolio. In Last 4 years we are dealing in Chronic Therapy and in 4 years we grow by 200% Annually, because we deal in high quality medicine. Steris medicine manufactures at WHO-GMP Approved Plants & We have Legal manufacturing contracts with all leading manufacturers of India. Today we have 1000+ Business Franchise Partners in PAN India. Steris's medicine supply in India's Top or Reputed Hospitals, Pharmacy, Government use or Railway use. Grow with a similar pace with the STERIS. Be first to launch like us.
For further information please contact:
contact@sterispharma.com
order now:
https://www.sterisonline.com/product/teneligold-pio-20-15-134077